{"schema_version":"secwatch.filing_event.v1","accession":"0001005286-24-000128","form_type":"8-K","ticker":"LFCR","cik":"0001005286","company_name":"LIFECORE BIOMEDICAL, INC. DE","filed_at":"2024-08-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.849729+00:00","generated_at":"2026-05-31T06:55:52.364643+00:00","sec_items":["3.02","5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lifecore appoints Ryan Lake as CFO effective Sept 3; Morberg departs Sept 2","bullets":["John Morberg steps down as CFO effective Sept 2, 2024; Ryan Lake succeeds him on Sept 3, 2024.","Lake receives $470K base salary, RSU for 262,500 shares, and PSU for up to 750,000 shares under Inducement Plan.","Lake previously served as CFO of Societal CDMO, leading its sale to CoreRx in April 2024.","Morberg's separation treated as termination without Cause after a Change in Control under his employment agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001005286-24-000128","json":"https://secwatch.observer/filing/0001005286-24-000128.json","markdown":"https://secwatch.observer/filing/0001005286-24-000128.md","text":"https://secwatch.observer/filing/0001005286-24-000128.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000128/0001005286-24-000128-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000128/lndc-20240828.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:55:52.364643+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ba19dafb14","claim":"Ryan D. Lake was appointed as Chief Financial Officer and Secretary at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"On August 28, 2024, the Company appointed Ryan D. Lake as the Company’s Chief Financial Officer and Secretary, effective September 3, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000128/0001005286-24-000128-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer and Secretary"}],"fact_type":"executive_change"},{"claim_id":"f3de27d65e","claim":"John D. Morberg departed as Chief Financial Officer and Secretary at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"Mr. Morberg's separation will be treated as a termination by the Company without Cause subsequent to a Change in Control under that certain Executive Employment Agreement (the \"Morberg Employment Agreement\"), dated January 19, 2021, between the Company and Mr. Morberg","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000128/0001005286-24-000128-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"employment will end"},{"label":"Role","value":"Chief Financial Officer and Secretary"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}